Hematologic Oncologist, Syed A. Abutalib, MD of Cancer Treatment Centers of America Appointed to Editorial Board of The ASCO Post
ZION, Ill., June 29, 2015 /PRNewswire-USNewswire/ -- Syed A. Abutalib, MD, Assistant Director of the Stem Cell Transplant and Cell Therapy program at Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center in Zion, Ill., has been selected as a member of the editorial board of The ASCO Post, a bimonthly newsletter of the American Society of Clinical Oncology (ASCO). The publication is distributed to more than 28,000 oncology and hematology professionals in the United States and covers such topics as clinical cancer research released at medical meetings and in journals worldwide, policy developments, and oncology practice issues.
As part of Dr. Abutalib's three-year term on the editorial board, he is co-authoring Hematology Expert Review, a monthly column that includes a case report detailing a particular hematologic condition. He is also the editor, with Maurie Markman, MD, President of CTCA Medicine & Science, of Cancer Consult: Expertise for Clinical Practice, a guide for oncology fellows and trainees which offers insights into the multidisciplinary care of patients through mini case studies in a question and answer format. The book is available on www.wiley.com.
Dr. Abutalib, who earned a medical degree from Dow Medical College in Karachi, Pakistan, joined CTCA in 2008. He completed an internal medicine residency with an emphasis in hematologic malignancies and bone marrow transplant at Cook County Hospital in Chicago, and a fellowship in hematology/oncology at the University of Illinois at Chicago (UIC). During his fellowship he participated in clinical leukemia research at Northwestern Hospital & University of Chicago.
In addition to writing two columns and serving on the editorial board for Clinical Oncology News, Dr. Abutalib has published several peer-reviewed journal articles and served as editor and chapter contributor for more than 25 medical books, case reports and publications. He has been published in such peer-reviewed journals as the American Journal of Hematology, Hematology and Oncology Clinics of North America, Current Pharmaceutical Biotechnology and the American Journal of Clinical Pathology and has written chapters for medical textbooks, including Acute Leukemias (2008), Evidence-Based Hematology (2008) and Expert Hematology & Oncology Essentials (2014). An active member of the Christian Children's Orphan Program, he also is a member of the American Society of Hematology and the American Society of Clinical Oncology. He continues to collaborate with experts in the area of hematology/oncology to explore new medical breakthroughs and treatment options in order to better educate, treat and care for his patients.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America® (CTCA), with headquarters in Boca Raton, Fla., is a national network of five hospitals that specialize in the treatment of patients fighting complex or advanced-stage cancer. CTCA offers an integrative approach to cancer treatment that combines surgery, radiation, and chemotherapy with nutritional counseling, naturopathic medicine, mind-body therapy, and spiritual support to enhance quality of life and minimize side effects during treatment. The company serves patients from around the world at hospitals located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowerment Medicine®, CTCA provides patients with comprehensive information about their treatment options so they can participate in their treatment decisions. For more information about CTCA, go to www.cancercenter.com, facebook.com/CancerCenter and twitter.com/CancerCenter.
About Cancer Treatment Centers of America at Midwestern Regional Medical Center
Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) is a 73 bed specialty hospital dedicated to treating patients battling complex cancer. CTCA at Midwestern is nationally recognized for providing innovative and individualized cancer care and has been designated by the American Nurses Credentialing Center (ANCC) a Magnet Recognized® program, ranking the hospital as one of the top seven percent in the nation for nursing excellence. CTCA at Midwestern has been designated by the National Quality Measures for Breast Centers Program (NQMBC®) as a Certified Quality Breast Center of Excellence™, ranking the hospital among the top centers in the country for quality breast cancer care. CTCA at Midwestern is the only Certified Breast Center of Excellence in Illinois, and one of only 50 nationally. As a member of the National Marrow Donor Program (NMDP) the hospital also offers a Stem Cell Transplant and Cell Therapy program that provides a full spectrum of transplantation services and advanced treatment options for hematologic cancers. CTCA is recognized by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration. CTCA at Midwestern is also recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO), for meeting the highest standards for quality cancer care. The hospital received a five star rating from the Centers for Medicare and Medicaid for patient satisfaction, the only hospital in Cook and the surrounding counties. CTCA at Midwestern is proud to use the latest technology to offer advanced treatment for cancer and is currently one of only a few hospitals in the nation to combine recent advances in brain mapping and navigation to perform minimally invasive brain surgery on hard to reach brain tumors.
Logo - http://photos.prnewswire.com/prnh/20090612/CTCALOGO
SOURCE Cancer Treatment Centers of America
Share this article